tldrdailynews.com logo

FDA Panel Endorses New COVID-19 Vaccine Targeting JN.1 Lineage for Fall

1 min read
Source: USA TODAY
FDA Panel Endorses New COVID-19 Vaccine Targeting JN.1 Lineage for Fall
Photo: USA TODAY
TL;DR Summary

A federal advisory panel has recommended that the new COVID-19 vaccine for fall should target the JN.1 lineage, which has been driving recent cases. The FDA is expected to use this recommendation to develop vaccines, with manufacturers like Pfizer, Moderna, and Novavax prepared to produce JN.1-targeted vaccines by August. This decision follows a decline in vaccination rates and aims to provide better protection against expected winter upticks in COVID-19 cases.

Topics:business#covid-19#fda#health#jn1-lineage#public-health#vaccine
Share this article
  1. New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel  USA TODAY
  2. New Covid Vaccine Endorsed for Fall  The New York Times
  3. FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall  CNN
  4. COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say  Reuters
  5. FDA considers updating COVID boosters, Novavax stock reacts  Yahoo Finance

Reading Insights

Total Reads

0

Unique Readers

14

Time Saved

2 min

vs 3 min read

Condensed

85%

474 → 70 words

Want the full story? Read the original article

Read on USA TODAY